Who to call at Quoin Pharmaceuticals Ltd., and when
Fundz watches for the moments Quoin Pharmaceuticals Ltd. starts buying, and tells you who to reach.
- An alert the day Quoin Pharmaceuticals Ltd. raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Quoin Pharmaceuticals Ltd., from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Quoin Pharmaceuticals Ltd.. With Fundz connected, it knows.
Quoin Pharmaceuticals Ltd.
A senior executive or director joined, left, or changed roles. An 8-K is the notice a US public company must file within four business days of a major event.
quoinpharma.comAI Executive Summary
AI-powered analysis of 8-K filing content
Quoin Pharmaceuticals' Compensation Committee approved new forms of stock option award agreements under its 2025 Equity Incentive Plan for directors and executive officers. The filing describes exercise payment methods and treatment of awards on termination, but discloses no dollar amounts or award sizes.
Key Takeaways
The Compensation Committee approved standard award agreement forms on November 14, 2025, for stock option grants to directors and executive officers under the 2025 Equity Incentive Plan.
Option exercise prices may be paid in cash, by certified or bank check, by wire transfer, through broker sale or loan pledge directions, through a Cashless Exercise Mechanism, or by other methods the
3 more takeaways
Related Filings (9)
9 more filings from Quoin Pharmaceuticals Ltd. in the last 90 days
Filing Overview
What This Means
Quoin Pharmaceuticals Ltd. filed with the SEC. Fundz turns 8-K material events into an alert with the right executive attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
4 screens from a live account. No signup.